h1

000982169 001__ 982169
000982169 005__ 20250207132722.0
000982169 0247_ $$2HSB$$aeva544424
000982169 0247_ $$2ISSN$$a2234-943X
000982169 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85175806708
000982169 0247_ $$2WOS$$aWOS:001170573400001
000982169 0247_ $$2datacite_doi$$a10.18154/RWTH-CONV-252232
000982169 0247_ $$2doi$$a10.3389/fonc.2023.1277453
000982169 0247_ $$2pmid$$apmid:37941547
000982169 037__ $$aRWTH-CONV-252232
000982169 041__ $$aEnglish
000982169 1001_ $$0P:(DE-82)943030$$aOlschok, Kathrin$$b0$$urwth
000982169 245__ $$aThe telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling$$honline
000982169 260__ $$aLausanne$$bFrontiers Media$$c2023
000982169 300__ $$a1-13
000982169 3367_ $$00$$2EndNote$$aJournal Article
000982169 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
000982169 3367_ $$0PUB:(DE-HGF)7$$2PUB:(DE-HGF)$$aContribution to a book
000982169 3367_ $$2BibTeX$$aARTICLE
000982169 3367_ $$2DRIVER$$aarticle
000982169 3367_ $$2DataCite$$aOutput Types/Journal article
000982169 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000982169 591__ $$aGermany
000982169 7001_ $$0P:(DE-588)1250519136$$aAltenburg, Bianca$$b1$$urwth
000982169 7001_ $$0P:(DE-588)1238644163$$ade Toledo, Marcelo A. S.$$b2$$urwth
000982169 7001_ $$0P:(DE-588)124497403X$$aMaurer, Angela$$b3$$urwth
000982169 7001_ $$0P:(DE-82)849946$$aAbels, Anne$$b4$$urwth
000982169 7001_ $$0P:(DE-588)138749027$$aBeier, Fabian$$b5$$urwth
000982169 7001_ $$0P:(DE-82)958140$$aGezer, Deniz$$b6$$urwth
000982169 7001_ $$0P:(DE-82)136034$$aIsfort, Susanne$$b7$$urwth
000982169 7001_ $$aPaeschke, Katrin$$b8
000982169 7001_ $$0P:(DE-82)IDM06025$$aBrümmendorf, Tim Henrik$$b9$$urwth
000982169 7001_ $$0P:(DE-82)IDM00384$$aZenke, Martin$$b10$$urwth
000982169 7001_ $$0P:(DE-82)042776$$aChatain, Nicolas$$b11$$eCorresponding author$$urwth
000982169 7001_ $$0P:(DE-82)IDM06178$$aKoschmieder, Steffen$$b12$$eCorresponding author$$urwth
000982169 770__ $$aBiological and Clinical Implications of the Mutational Landscape in Myeloproliferative Neoplasms
000982169 773__ $$0PERI:(DE-600)2649216-7$$a10.3389/fonc.2023.1277453$$p1277453$$tFrontiers in oncology$$v13$$x2234-943X
000982169 8564_ $$uhttps://publications.rwth-aachen.de/record/982169/files/982169.pdf$$yOpenAccess
000982169 909CO $$ooai:publications.rwth-aachen.de:982169$$pVDB$$pdnbdelivery$$pdriver$$popen_access$$popenaire
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)943030$$aRWTH Aachen$$b0$$kRWTH
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-588)1250519136$$aRWTH Aachen$$b1$$kRWTH
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-588)1238644163$$aRWTH Aachen$$b2$$kRWTH
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-588)124497403X$$aRWTH Aachen$$b3$$kRWTH
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)849946$$aRWTH Aachen$$b4$$kRWTH
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-588)138749027$$aRWTH Aachen$$b5$$kRWTH
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)958140$$aRWTH Aachen$$b6$$kRWTH
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)136034$$aRWTH Aachen$$b7$$kRWTH
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06025$$aRWTH Aachen$$b9$$kRWTH
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM00384$$aRWTH Aachen$$b10$$kRWTH
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)042776$$aRWTH Aachen$$b11$$kRWTH
000982169 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06178$$aRWTH Aachen$$b12$$kRWTH
000982169 9141_ $$y2023
000982169 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
000982169 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000982169 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT ONCOL : 2022$$d2023-10-26
000982169 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-26
000982169 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
000982169 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-26
000982169 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
000982169 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
000982169 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
000982169 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-26
000982169 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-11T13:25:45Z
000982169 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-11T13:25:45Z
000982169 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000982169 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-26
000982169 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-26
000982169 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-26
000982169 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-26
000982169 9201_ $$0I:(DE-82)531040-2_20140620$$k531040-2$$lKlinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)$$x0
000982169 961__ $$z2024-03-15
000982169 970__ $$aeva544424
000982169 9801_ $$aFullTexts
000982169 980__ $$aI:(DE-82)531040-2_20140620
000982169 980__ $$aUNRESTRICTED
000982169 980__ $$aVDB
000982169 980__ $$acontb
000982169 980__ $$ajournal